Teva Breaks into Injectable Generics with its US$3.4 B Acquisition of SICOR
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 42 (Table of Contents)
Published: 3 Dec-2003
DOI: 10.3833/pdr.v2003.i42.848 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Teva Pharmaceutical Industries entered into an agreement to acquire SICOR for approximately US$3...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS